NCT05080829

Myeloid Mutations Register in R/R CML

ABL Mutation Register in Patients With ITK Relapsed or Refractory Chronic Myeloid Leukemia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 29 (estimated)
• Sponsor: Grupo Cooperativo de Hemopatías Malignas · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to know the percentage of ABL mutations in patients with chronic myeloid leukemia that relapsed or are refractory to tyrosine-kinase inhibitors measured with a myeloid mutations panel by NGS.

Conditions

• Chronic Myeloid Leukaemia Recurrent
• Chronic Myeloid Leukemia, in Relapse

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Myeloid mutations measurement	Measure of myeloid mutations by NGS when detection of refractory or relapsed CML is done

Timeline

• Start date: 2021-03-01
• Primary completion: 2022-02-28
• Completion: 2022-03-30
• First posted: 2021-10-18
• Last updated: 2021-10-18

Locations

1 site across 1 country: Mexico